D
PreveCeutical Medical Inc.
PRVCF
$0.015
-$0.0009-5.66%
D
Sell
1/7/2025Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 1/7/2025 due to a substantial increase in the total return index and volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 1/7/2025 due to a substantial increase in the total return index and volatility index.
E
Sell
9/12/2024Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 9/12/2024 due to a substantial decline in the total return index, growth index and volatility index. Operating cash flow declined 221.71% from -$43.3 to -$139.3, EBIT declined 89.15% from -$96.8 to -$183.1, and earnings per share declined from -$0.0003 to -$0.0005.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 9/12/2024 due to a substantial decline in the total return index, growth index and volatility index. Operating cash flow declined 221.71% from -$43.3 to -$139.3, EBIT declined 89.15% from -$96.8 to -$183.1, and earnings per share declined from -$0.0003 to -$0.0005.
D
Sell
8/1/2024Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 8/1/2024 due to an increase in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 8/1/2024 due to an increase in the volatility index.
E
Sell
7/17/2024Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 7/17/2024 due to a decline in the volatility index and valuation index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 7/17/2024 due to a decline in the volatility index and valuation index.
D
Sell
7/3/2024Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 7/3/2024 due to an increase in the valuation index and volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 7/3/2024 due to an increase in the valuation index and volatility index.
E
Sell
6/25/2024Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 6/25/2024 due to a decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 6/25/2024 due to a decline in the volatility index.
D
Sell
5/20/2024Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 5/20/2024 due to an increase in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 5/20/2024 due to an increase in the volatility index.
E
Sell
5/3/2024Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 5/3/2024 due to a noticeable decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 5/3/2024 due to a noticeable decline in the volatility index.
D
Sell
4/18/2024Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 4/18/2024 due to an increase in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 4/18/2024 due to an increase in the volatility index.
E
Sell
4/2/2024Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 4/2/2024 due to a decline in the volatility index and valuation index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 4/2/2024 due to a decline in the volatility index and valuation index.
D
Sell
3/18/2024Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 3/18/2024 due to an increase in the volatility index, valuation index and total return index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 3/18/2024 due to an increase in the volatility index, valuation index and total return index.
E
Sell
2/29/2024Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 2/29/2024 due to a decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 2/29/2024 due to a decline in the volatility index.
D
Sell
2/14/2024Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 2/14/2024 due to an increase in the volatility index and total return index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 2/14/2024 due to an increase in the volatility index and total return index.
E
Sell
1/30/2024Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 1/30/2024 due to a decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 1/30/2024 due to a decline in the volatility index.
D
Sell
1/10/2024Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 1/10/2024 due to an increase in the volatility index and growth index. Operating cash flow increased 58.17% from -$86.3 to -$36.1, and EBIT increased 3.89% from -$110.5 to -$106.2.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 1/10/2024 due to an increase in the volatility index and growth index. Operating cash flow increased 58.17% from -$86.3 to -$36.1, and EBIT increased 3.89% from -$110.5 to -$106.2.
E
Sell
3/20/2023Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 3/20/2023 due to a noticeable decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 3/20/2023 due to a noticeable decline in the volatility index.
D
Sell
3/14/2023Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 03/14/2023.
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 02/23/2023.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 0.02 to 0.01.
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 0.02 to 0.01.
D
Sell
5/16/2022Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from E+ on 05/16/2022.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
D
Sell
5/6/2022Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from E+ on 5/6/2022 due to an increase in the growth index and volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from E+ on 5/6/2022 due to an increase in the growth index and volatility index.
E
Sell
5/1/2022Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 4/20/2022 due to a large decline in the solvency index and growth index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 4/20/2022 due to a large decline in the solvency index and growth index.
D
Sell
11/9/2021Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from E+ on 11/09/2021.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the total return index, volatility index and valuation index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the total return index, volatility index and valuation index.
D
Sell
5/18/2021Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 5/18/2021 due to a noticeable increase in the total return index and volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 5/18/2021 due to a noticeable increase in the total return index and volatility index.
D
Sell
4/14/2021Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 4/14/2021 due to a noticeable decline in the total return index, volatility index and growth index. Earnings per share declined from $0.0007 to -$0.0026, EBIT declined 462.15% from $324.2 to -$1.17M, and operating cash flow declined 124.48% from $390.5 to -$95.6.
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 4/14/2021 due to a noticeable decline in the total return index, volatility index and growth index. Earnings per share declined from $0.0007 to -$0.0026, EBIT declined 462.15% from $324.2 to -$1.17M, and operating cash flow declined 124.48% from $390.5 to -$95.6.
D
Sell
8/7/2020Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 8/7/2020 due to a major increase in the total return index, volatility index and solvency index. Debt to equity declined from -0.99 to -1.01.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 8/7/2020 due to a major increase in the total return index, volatility index and solvency index. Debt to equity declined from -0.99 to -1.01.
D
Sell
5/19/2020Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 5/19/2020 due to a significant decline in the efficiency index, growth index and total return index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 5/19/2020 due to a significant decline in the efficiency index, growth index and total return index.
D
Sell
4/20/2020Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to D from D+ on 4/20/2020 due to a substantial decline in the solvency index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to D from D+ on 4/20/2020 due to a substantial decline in the solvency index.
D
Sell
4/3/2020Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D+ from D on 4/3/2020 due to an increase in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D+ from D on 4/3/2020 due to an increase in the volatility index.
D
Sell
3/18/2020Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to D from D+ on 3/18/2020 due to a decline in the volatility index and total return index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to D from D+ on 3/18/2020 due to a decline in the volatility index and total return index.
D
Sell
1/30/2020Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D+ from D on 1/30/2020 due to an increase in the volatility index and total return index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D+ from D on 1/30/2020 due to an increase in the volatility index and total return index.
D
Sell
11/29/2019Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 11/29/2019 due to a significant increase in the efficiency index and growth index. Operating cash flow increased 86.28% from -$301.8 to -$41.4, net income increased 63.89% from -$1.28M to -$462.6, and earnings per share increased from -$0.0032 to -$0.0012.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 11/29/2019 due to a significant increase in the efficiency index and growth index. Operating cash flow increased 86.28% from -$301.8 to -$41.4, net income increased 63.89% from -$1.28M to -$462.6, and earnings per share increased from -$0.0032 to -$0.0012.
D
Sell
8/28/2019Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 8/28/2019 due to a decline in the solvency index, growth index and total return index. The quick ratio declined from 0.09 to 0.04, earnings per share declined from -$0.0023 to -$0.0032, and EBIT declined 28.01% from -$787.1 to -$1.01M.
PreveCeutical Medical Inc. (PRVCF) was downgraded to D- from D on 8/28/2019 due to a decline in the solvency index, growth index and total return index. The quick ratio declined from 0.09 to 0.04, earnings per share declined from -$0.0023 to -$0.0032, and EBIT declined 28.01% from -$787.1 to -$1.01M.
D
Sell
5/31/2019Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 5/31/2019 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 283.33% from $600 to $2.3, earnings per share increased from -$0.0112 to -$0.0023, and operating cash flow increased 42.26% from -$823.7 to -$475.6.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 5/31/2019 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 283.33% from $600 to $2.3, earnings per share increased from -$0.0112 to -$0.0023, and operating cash flow increased 42.26% from -$823.7 to -$475.6.
D
Sell
4/23/2019Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 4/23/2019 due to an increase in the efficiency index, valuation index and growth index. Operating cash flow increased 36.05% from -$1.29M to -$823.7.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 4/23/2019 due to an increase in the efficiency index, valuation index and growth index. Operating cash flow increased 36.05% from -$1.29M to -$823.7.
E
Sell
1/18/2019Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 1/18/2019 due to a large decline in the growth index, efficiency index and volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D on 1/18/2019 due to a large decline in the growth index, efficiency index and volatility index.
D
Sell
11/28/2018Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 11/28/2018 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 57.22% from -$3.01M to -$1.29M, and earnings per share increased from -$0.0067 to -$0.0051.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D from D- on 11/28/2018 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 57.22% from -$3.01M to -$1.29M, and earnings per share increased from -$0.0067 to -$0.0051.
D
Sell
11/8/2018Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 11/8/2018 due to an increase in the total return index, volatility index and valuation index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 11/8/2018 due to an increase in the total return index, volatility index and valuation index.
E
Sell
10/24/2018Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 10/24/2018 due to a decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 10/24/2018 due to a decline in the volatility index.
D
Sell
10/9/2018Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 10/9/2018 due to an increase in the volatility index, growth index and total return index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 10/9/2018 due to an increase in the volatility index, growth index and total return index.
E
Sell
9/4/2018Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 9/4/2018 due to a noticeable decline in the solvency index, volatility index and total return index. Debt to equity increased from -2.63 to 1.17.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E+ from D- on 9/4/2018 due to a noticeable decline in the solvency index, volatility index and total return index. Debt to equity increased from -2.63 to 1.17.
D
Sell
5/2/2018Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 5/2/2018 due to an increase in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to D- from E+ on 5/2/2018 due to an increase in the volatility index.
E
Sell
5/1/2018Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to E+ from E on 5/1/2018 due to an increase in the valuation index, solvency index and growth index. Operating cash flow increased 1.38% from -$1.2M to -$1.18M, EBIT increased 1.38% from -$1.36M to -$1.34M, and earnings per share increased from -$0.0583 to -$0.0575.
PreveCeutical Medical Inc. (PRVCF) was upgraded to E+ from E on 5/1/2018 due to an increase in the valuation index, solvency index and growth index. Operating cash flow increased 1.38% from -$1.2M to -$1.18M, EBIT increased 1.38% from -$1.36M to -$1.34M, and earnings per share increased from -$0.0583 to -$0.0575.
E
Sell
2/1/2018Upgraded
PreveCeutical Medical Inc. (PRVCF) was upgraded to E from E- on 2/1/2018 due to an increase in the total return index, valuation index and solvency index.
PreveCeutical Medical Inc. (PRVCF) was upgraded to E from E- on 2/1/2018 due to an increase in the total return index, valuation index and solvency index.
E
Sell
11/14/2017Downgrade
PreveCeutical Medical Inc. (PRVCF) was downgraded to E- from E on 11/14/2017 due to a large decline in the volatility index.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E- from E on 11/14/2017 due to a large decline in the volatility index.
E
Sell
11/13/2017None
PreveCeutical Medical Inc. (PRVCF) was downgraded to E from U on 11/13/2017.
PreveCeutical Medical Inc. (PRVCF) was downgraded to E from U on 11/13/2017.
OTC PK
04/02/2025 2:22PM Eastern
Quotes delayed
